Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
5 things to know before the stock market opens
Tags Technology Novo Nordisk A/S Paramount Global
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Eli Lilly and Co Asia: Top News and Analysis Asia News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Companies US: News Biotechnology
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Europe News Novo Nordisk A/S Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Eli Lilly and Co Health care industry Healthy Returns
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Business Pharmaceuticals Health & Science
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags Prices Voting Ibex Ltd
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Employee benefits Weight loss diets Employee healthcare benefits
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Eli Lilly and Co Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Great Lakes Dredge & Dock Corp Tegna Inc Business
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Eli Lilly and Co Zealand Pharma A/S Exchange/traded funds
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Hims & Hers Health Inc Breaking News: Technology Health & Science
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Eli Lilly and Co Science Health care industry
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags AstraZeneca PLC Novo Nordisk A/S Europe News
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Internet Enterprise Technology
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Roche Holding AG Eli Lilly and Co Health care industry
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Social issues Health & Science Novo Nordisk A/S
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Business News Health & Science Biotechnology
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Healthy Returns Apple Inc Eli Lilly and Co
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Health & Science Business News US: News
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Amgen Inc
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Eli Lilly and Co Health care industry Earnings
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Novo Nordisk A/S Pharmaceuticals Earnings
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Health care industry Novartis AG Politics
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Health & Science Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Restaurants Chipotle Mexican Grill Inc CAVA Group Inc
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Pharmaceuticals Business Breaking news
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Business News Health & Science Biotechnology
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.